# Nilotinib

NDC: 69097-032
Generic name: Nilotinib
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250618

FDA application: NDA218922

## Active ingredients

- NILOTINIB: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-032"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-032
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e27c3e09-bc4f-4f01-be05-1c43ac72285d